바로가기 및 건너띄기 링크
본문 바로가기
주메뉴 바로가기

컨설팅 신청

home > 전문가 컨설팅> 온라인 컨설팅서비스> 컨설팅 신청

글자크기

GPKOL 온라인 자문 신청서 양식 다운로드(신청자 회사 소속확인, 회사직인)

GPKOL 자문위원 리스트

전체 255건, 현재 페이지 18/26

  • 이승호 (Seongho Lee)
    • 컨설팅 구분

      GPKOL

    • 컨설팅 분야

      R & D기획

    • 컨설팅 대상 지역

      대한민국

    • 컨설팅내용

      Drug Screening
      Assay development for the high throughput screening (Enzyme, GPCR, Protein-protein interactions, Etc.)
      Detection Technology
      Design of fluorescence based applications, Photoprotein based detection, Instrumental comparisons for multimode detectors
      Lab. automation
      Laboratory automation relating to HTS system including data analysis system

  • 이광호
    • 컨설팅 구분

      GPKOL

    • 컨설팅 분야

      임상

    • 컨설팅 대상 지역

      대한민국

    • 컨설팅내용

      •Translational Research Institute of Novel Drug (TREND) Director
      •Discovery of LFF571 a novel Elongation Factor Tu (EFTU) inhibitor currently Phase2.
      •Discovery of LBM415 Peptide Deformylase Inhibitors (PDF) terminated after Phase1.

  • 오의철
    • 컨설팅 구분

      GPKOL

    • 컨설팅 분야

      GMP
      R & D기획

    • 컨설팅 대상 지역

      대한민국

    • 컨설팅내용

      Pharmaceutics
      Industrial Pharmacy
      R&D-Planning, Preformulation & Formulation
      Project Management

  • 손우찬
    • 컨설팅 구분

      GPKOL

    • 컨설팅 분야

      R & D기획

    • 컨설팅 대상 지역

      대한민국

    • 컨설팅내용

      Engaged in teaching and research in the pathology department. Teaching of experimental animal pathology. Providing consultancy in the area of comparative pathology. A member of IRB in Asan Medical Center. Advisory activities with the clinical study groups in the Hospital. Leading the experimental pathology conference. Organised the consultancy group together with early clinical clinicians, PRISM, providing consulting service to pharma industries.

      Have been involved in the gross and histopathological examination of a wide range of laboratory species from short-term to long-term toxicological studies. Special interests are preclinical safety evaluation and academic research areas are GEM (Genetically Engineered Mice) pathological phenotyping.

  • 백태곤
    • 컨설팅 구분

      GPKOL

    • 컨설팅 분야

      임상

    • 컨설팅 대상 지역

      대한민국

    • 컨설팅내용

      - drug discovery and development in the field of cancer,
      - inflammation and metabolism
      - establishment of strategy of the development of new projects
      - licensing in collaborating with team of new business development
      - construct a strategic alliance with pharmaceutical
      - bio-venture companies as a part of open innovation to build up a strong pipeline
      - explore new business opportunities over 20 years in the pharmaceutical companies in Korea and US.

  • 백경원 (Kyung Won Baik)
    • 컨설팅 구분

      GPKOL

    • 컨설팅 분야

      기술마케팅

    • 컨설팅 대상 지역

      브라질

    • 컨설팅내용

      - Risk management specialist
      - Established commercial relationship with the accredited clinical trial centers
      - ANVISA regulatory affairs

  • 문예실
    • 컨설팅 구분

      GPKOL

    • 컨설팅 분야

      R & D기획
      PM

    • 컨설팅 대상 지역

      미국

    • 컨설팅내용

      New York State Bar, The United States Patent and Trademark Office, Korean Intellectual Property Office, New York State Pharmacist License, and Korea Pharmacist License

  • 김재범
    • 컨설팅 구분

      GPKOL

    • 컨설팅 분야

      임상

    • 컨설팅 대상 지역

      미국

    • 컨설팅내용

      - Mammalian cell & molecular biologist in Regenerative Medicine, Cancer Biology, and Stem Cell Biology.
      - New business development inAsia Pacific regions.
      - Excellent team player and skillful troubleshooter.
      - Independently develop and manage multiple projects.
      - Proven management skills in industry and academic settings.
      - Excellent communication and presentation skills.

  • 김성헌
    • 컨설팅 구분

      GPKOL

    • 컨설팅 분야

      R & D기획

    • 컨설팅 대상 지역

      대한민국

    • 컨설팅내용

      Chemistry / Organic Chemistry

  • Christopher Berry
    • 컨설팅 구분

      GPKOL

    • 컨설팅 분야

      임상
      R & D기획

    • 컨설팅 대상 지역

      영국

    • 컨설팅내용

      Drug Discovery
      From 1984 to 2000 performed drug discovery in inflammation gastroenterology allergy and thrombosis (Head of Thrombosis at Synthélabo from 1990 -2000)

      R&D Business Development
      Since 2000, have established early stage collaborations ranging from licensing cell lines to large scale drug discovery programmes in neglected tropical diseases, infectious diseases, biologics, and HCC including 17 contracts in the Asia-Pacific region. Currently member of Business Development Advisory Board, Institut Pasteur Korea

      Project Management
      Chaired Pre-clinical development teams for SL86.0773 (anti-inflammatory, 1986 -1990).
      Pre-clinical development of mixed micellar formulation of Argatroban (1998, see Berry et al, Thrombos. Haemostas. 84, 278-285, 2000 & Thrombos. Haemostas. 84, 286-290, 2000.)